Crossmark

Comment on “The combination of glucagon-like peptide-1 receptor agonists and sodium–glucose cotransporter-2 inhibitors: a narrative review of existing meta-analysis”

Crossref DOI link: https://doi.org/10.1007/s00592-026-02700-w

Published Online: 2026-05-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cao, Bin

Ouyang, Ming https://orcid.org/0009-0002-1416-659X
License Information

Text and Data Mining valid from 2026-05-06

Version of Record valid from 2026-05-06
More Information

Article History

Received: 8 March 2026

Accepted: 29 March 2026

First Online: 6 May 2026

Declarations

:

: The authors declare that they have no competing interests. The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

: The work has not been published previously and it is not under consideration for publication elsewhere.

Document is current

Any future updates will be listed below